Related Experiment Videos
Value of routine vascular laboratory studies to identify vein graft stenosis
Insights
Early detection of vein graft stenosis using ankle-brachial index (ABI) measurements is crucial. Regular ABI monitoring is more sensitive than clinical exams for identifying stenosis before graft occlusion, enabling successful angioplasty.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Vascular Disease
Background:
- Vein graft stenosis is a significant complication following bypass surgery.
- Early detection is vital to prevent graft occlusion and limb ischemia.
- Clinical assessment alone may not reliably identify early-stage stenosis.
Purpose of the Study:
- To evaluate the sensitivity of ankle systolic pressure index (ASPI) measurements compared to clinical examination in detecting vein graft stenosis.
- To assess the efficacy of percutaneous transluminal angioplasty (PTA) for treating stenotic vein grafts.
Main Methods:
- Retrospective analysis of 30 patients with 33 stenotic vein grafts (femoral-popliteal and femoral-tibial).
- Comparison of clinical findings (pulses, symptoms) with ASPI measurements.
- Assessment of PTA outcomes and graft patency rates.
Main Results:
- 77% of stenoses occurred within 1 year post-surgery.
- 57% of patients were asymptomatic with normal pulses, highlighting limitations of clinical exams.
- ASPI decreased significantly (0.83 to 0.57) with stenosis development.
- 24 of 30 stenotic grafts treated with PTA remained patent at 24 months (80% patency).
Conclusions:
- Frequent vascular laboratory measurements of ASPI are more sensitive than clinical examinations for early detection of vein graft stenosis.
- Early diagnosis and treatment of vein graft stenosis with PTA can preserve graft function and prevent occlusion.
- Nonoperative management with PTA is a highly effective treatment for most vein graft stenoses.
Abstract:
Thirty-three stenotic lesions were found in 30 vein grafts (17 femoral-popliteal, 13 femoral-tibial) 3 months to 8 years postoperatively--77% appeared within 1 year of surgery. Seventeen (57%) of the patients presented with normal distal pulses, and a similar number were asymptomatic. Only eight (26%) presented with unequivocal clinical evidence of graft stenosis based on decreased pulses and return of ischemic symptoms. Forty percent were completely asymptomatic with normal distal pulses. The mean postoperative ankle systolic pressure index (ASPI) was 0.83 +%- 0.03 (SEM); it fell to 0.57 +/- 0.04 (SEM) when stenosis developed. The peripheral vascular laboratory measurements were the key factor influencing the decision for repeat arteriography in many of these patients and reinforced the need for a repeat arteriogram when the clinical diagnosis was unclear. Early diagnosis of vein graft lesions prior to graft occlusions allowed 24 of 30 of these stenotic grafts to be treated primarily by percutaneous transluminal angioplasty (PTA); 80% remained patent 24 months after PTA. Since most vein graft stenoses can be treated by such a simple, nonoperative technique (PTA), every effort should be made to diagnose and treat lesions prior to graft occlusion. Our experience indicates that frequent vascular laboratory measurements of ASPI are more sensitive then clinical examinations in detecting early vein graft stenosis.